Natural Killer Cells Modulation in Hematological Malignancies

Hematological malignancies (HM) treatment improved over the last years resulting in increased achievement of complete or partial remission, but unfortunately high relapse rates are still observed, due to remaining minimal residual disease. Therefore, sustainment of long-term remission is crucial, us...

Descripción completa

Detalles Bibliográficos
Autores principales: Baier, Céline, Fino, Aurore, Sanchez, Carole, Farnault, Laure, Rihet, Pascal, Kahn-Perlès, Brigitte, Costello, Régis T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867693/
https://www.ncbi.nlm.nih.gov/pubmed/24391641
http://dx.doi.org/10.3389/fimmu.2013.00459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867693/
https://www.ncbi.nlm.nih.gov/pubmed/24391641
http://dx.doi.org/10.3389/fimmu.2013.00459

Ejemplares similares